SCHEMBL580855

SCHEMBL580855

Cc1ccc(-c2nc(-c3ccc(O)cc3O)nc(-c3ccc(O)cc3O)n2)c(C)c1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ESR2 Q92731 6/20 0.47
ESR1 P03372 6/20 0.47
TP53 P04637 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
MGAM O43451 1/20 0.41
GAA P10253 1/20 0.41
SI P14410 1/20 0.41
MGAM2 Q2M2H8 1/20 0.41
HSD17B1 P14061 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2C19 P33261 1/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
ALDH1A1 P00352 1/20 0.40
MAPT P10636 1/20 0.40
ALOX12 P18054 1/20 0.40
MAPK10 P53779 1/20 0.40
ATM Q13315 1/20 0.40
NPC1 O15118 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29350280 1.00 ESR2 (0.47) ESR2ESR1TP53TDP1MGAM
SCHEMBL29358205 1.00 ESR2 (0.47) ESR2ESR1TP53TDP1MGAM
SCHEMBL39158 1.00 ESR2 (0.47) ESR2ESR1TP53TDP1MGAM
SCHEMBL28968047 0.92 KMT2A (0.50) ESR2TDP1CYP1A2CYP2C19MEN1
SCHEMBL4207204 0.92 ESR2 (0.49) ESR2ESR1TP53TDP1GAA
SCHEMBL4209528 0.92 ESR2 (0.43) ESR2ESR1TP53TDP1MGAM
SCHEMBL9608578 0.91 TP53 (0.50) ESR2ESR1TP53TDP1GAA
SCHEMBL92073 0.91 TP53 (0.50) ESR2ESR1TP53TDP1GAA
SCHEMBL2354543 0.90 ESR2 (0.42) ESR2ESR1TP53TDP1MGAM
SCHEMBL6471538 0.90 ESR2 (0.45) ESR2ESR1TP53TDP1MGAM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 906 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260146144-A1 SYNERGISTIC STABILIZER COMPOSITIONS AND METHODS FOR USING SAME FOR PROTECTING ORGANIC MATERIALS FROM UV LIGHT AND THERMAL DEGRADATION CYTEC INDUSTRIES INC. (US) 2026-05-28 US claimed
EP-3786216-B1 PROCESSING ADDITIVES AND USES OF SAME IN ROTATIONAL MOLDING CYTEC TECH CORP (US) 2026-02-11 EP claimed
EP-4574892-A1 BARIUM MAGNESIUM SILICATES AND ORTHO-HYDROXYPHENYL TRIAZINE UV ABSORBERS IN A GREENHOUSE FILM RHODIA OPERATIONS (FR) 2025-06-25 EP claimed
US-12227635-B2 Stabilizer compositions and methods for using same for protecting polymeric organic materials from UV light and thermal degradation CYTEC INDUSTRIES INC. (US) 2025-02-18 US claimed
EP-3137540-B1 STABILIZING COMPOSITIONS FOR STABILIZING MATERIALS AGAINST ULTRAVIOLET LIGHT AND THERMAL DEGRADATION CYTEC IND INC (US) 2024-10-30 EP claimed
EP-2864310-B1 STABILIZER COMPOSITIONS CONTAINING SUBSTITUTED CHROMAN COMPOUNDS AND METHODS OF USE CYTEC TECH CORP (US) 2022-10-26 EP claimed
US-20220212375-A1 POLYMERIC HOLLOW ARTICLES CONTAINING CHROMAN-BASED COMPOUNDS AND MADE BY ROTATIONAL MOLDING CYTEC TECHNOLOGY CORP. 2022-07-07 US claimed
US-20220153959-A1 POLYOLEFIN COMPOSITIONS CONTAINING SUBSTITUTED CHROMAN COMPOUNDS AND MOLDED ARTICLES PRODUCED THEREFROM CYTEC TECHNOLOGY CORP. 2022-05-19 US claimed
US-20210403690-A1 STABILIZER COMPOSITIONS AND METHODS FOR USING SAME FOR PROTECTING POLYMERIC ORGANIC MATERIALS FROM UV LIGHT AND THERMAL DEGRADATION CYTEC INDUSTRIES INC. (US) 2021-12-30 US claimed
US-11091615-B2 Stabilizer compositions and methods for using same for protecting organic materials from UV light and thermal degradation CYTEC INDUSTRIES INC. (US) 2021-08-17 US claimed
WO-2013188490-A1 STABILIZER COMPOSITIONS CONTAINING SUBSTITUTED CHROMAN COMPOUNDS AND METHODS OF USE CYTEC TECHNOLOGY CORP. (US) 2013-12-19 WO claimed
EP-2652014-A2 PROCESSING ADDITIVES AND USES OF SAME IN ROTATIONAL MOLDING Cytec Technology Corp. (US) 2013-10-23 EP claimed
US-20130145962-A1 Stabilizer Compositions Containing Substituted Chroman Compounds and Methods of Use CYTEC TECHNOLOGY CORP. (US) 2013-06-13 US claimed
WO-2012082578-A2 PROCESSING ADDITIVES AND USES OF SAME IN ROTATIONAL MOLDING CYTEC TECHNOLOGY CORP. (US) 2012-06-21 WO claimed
US-20120146257-A1 PROCESSING ADDITIVES AND USES OF SAME IN ROTATIONAL MOLDING CYTEC TECHNOLOGY CORP. (US) 2012-06-14 US claimed
US-7867294-B2 Triazine compounds for removing acids and water from nonaqueous electrolytes for electrochemical cells NOVOLYTE TECHNOLOGIES INC. (US) 2011-01-11 US claimed
US-20100192363-A1 Triazine Compounds For Removing Acids And Water From Nonaqueous Electrolytes For Electrochemical Cells FERRO CORPORATION (US) 2010-08-05 US claimed
US-7727669-B2 Triazine compounds for removing acids and water from nonaqueous electrolytes for electrochemical cells NOVOLYTE TECHNOLOGIES INC. (US) 2010-06-01 US claimed
US-20060269844-A1 Triazine compounds for removing acids and water from nonaqueous electrolytes for electrochemical cells FERRO CORPORATION (US) 2006-11-30 US claimed
EP-0704560-B1 Stabilization of pigmented fiber with a synergistic mixture of hindered amine and UV absorber CIBA GEIGY AG (CH) 1999-01-13 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220212375-A1 POLYMERIC HOLLOW ARTICLES CONTAINING CHROMAN-BASED COMPOUNDS AND MADE BY ROTATIONAL MOLDING RPS7, MRPS27, F7 ESR2 4487/4885ESR1 4567/4885TP53 2292/4885
US-20220153959-A1 POLYOLEFIN COMPOSITIONS CONTAINING SUBSTITUTED CHROMAN COMPOUNDS AND MOLDED ARTICLES PRODUCED THEREFROM NOTUM, PMM2, WASF2 ESR2 4429/4885ESR1 4174/4885TP53 3294/4885
US-20260146144-A1 SYNERGISTIC STABILIZER COMPOSITIONS AND METHODS FOR USING SAME FOR PROTECTING ORGANIC MATERIALS FROM UV LIGHT AND THERMAL DEGRADATION RAD52, XRCC6, RAD23B ESR2 2108/4885ESR1 2113/4885TP53 2773/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.